Filter
Compound repurposing
Filters
Small molecule compounds are being studied for repurposing in COVID-19 treament and research. Multiple small molecules that are approved to treat other disorders have shown potential effects on key proteins involved in SARS-CoV-2 host cell entry and replication. Repurposing of existing compounds is advantageous for speed - reducing timescales compared to conventional drug discovery. Researchers can save up to 50% on these small molecules for COVID-19 research, as they are up to half the price of other suppliers.
(-)-[3R,4S]-Chromanol 293B (HB1076)
Description:Selective delayed rectifier K+ current inhibitor
Purity:>98%
ω-Conotoxin GVIA (HB1218)
Description:Potent, selective Cav2.2 (N-type) channel blocker
Purity:>98%
ω-Conotoxin MVIIC (HB1219)
Description:N-, P- and Q-type voltage-dependent Ca2+ channel blocker
Purity:>99%